<DOC>
	<DOCNO>NCT00625547</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety cabergoline compare levodopa treatment patient RLS .</brief_summary>
	<brief_title>A Study Determine Efficacy Safety Cabergoline Treatment Patients With RLS</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Cabergoline</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Diagnosis idiopathic RLS 4 clinical manifestation RLS Moderate severe symptom RLS indicate IRLSSGRS total score great equal 10 severity night score great equal 4 11point RLS6 rating scale No previous treatment RLS dissatisfaction current therapy Not available</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>